Skip to main content
. Author manuscript; available in PMC: 2023 Jan 20.
Published in final edited form as: Cardiovasc Eng Technol. 2021 Feb 9;12(3):325–338. doi: 10.1007/s13239-021-00522-1

Table 1:

Cell phenotypes of PBMC populations isolated from the LRS chambers and analyzed by flow cytometry. Data is presented as the mean percentage +/− standard deviation of the total cell population (n=3). Numbers in parentheses are the mean percentage from the gating population shown in parentheses. The ‘Other’ cell population is the remaining CD45 + cells after the lymphocytes, monocytes, and endothelial progenitor cells (EPCs) were identified and contains cells such as natural killer cells, neutrophils, and dendritic cells.

Cell Type
Live 87.94% +/− 9.41%
CD45+ 95.13% +/− 6.00%
Lymphocytes 52.18% +/− 5.80%
CD4+ (% of Lymphs) 41.35% +/− 6.05% (79.27% +/−7.99%)
CD8+ (% of Lymphs) 10.69% +/− 4.10% (20.44% +/− 7.83%)
DP+ T Cells (CD4+,CD8+) (% of Lymphs) 0.15% +/− 0.08% (0.29% +/− 0.17%)
Monocytes 7.83% +/− 3.69%
Mon1 (CD14+) (% of Monos) 7.21% +/− 3.85% (90.12% +/− 6.41%)
Mon 2 (CD14+CD16+) (% of Monos) 0.61% +/− 017% (9.68% +/− 6.48%)
CD192+ 15.18% +/− 5.82%
EPCs 0.10% +/− 0.03%
Other 39.88% +/− 2.95%